Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $18,655 - $22,671
71 New
71 $22,000
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $404,773 - $456,632
1,583 Added 2638.33%
1,643 $473,000
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $89,646 - $111,298
-410 Reduced 87.23%
60 $16,000
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $49,282 - $58,275
-230 Reduced 32.86%
470 $104,000
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $225,790 - $275,200
-1,000 Reduced 58.82%
700 $169,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $3.38 Million - $4.29 Million
-14,741 Reduced 89.66%
1,700 $446,000
Q3 2022

Nov 02, 2022

BUY
$224.46 - $253.15 $3.19 Million - $3.6 Million
14,231 Added 643.94%
16,441 $3.71 Million
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $1.39 Million - $1.55 Million
-6,022 Reduced 73.15%
2,210 $538,000
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $343,815 - $380,349
-1,568 Reduced 16.0%
8,232 $1.99 Million
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $816,601 - $934,525
4,106 Added 72.11%
9,800 $2.21 Million
Q3 2021

Oct 20, 2021

BUY
$212.27 - $248.7 $271,917 - $318,584
1,281 Added 29.03%
5,694 $1.21 Million
Q2 2021

Jul 19, 2021

SELL
$233.58 - $259.14 $487,247 - $540,566
-2,086 Reduced 32.1%
4,413 $1.08 Million
Q1 2021

Apr 14, 2021

SELL
$221.91 - $258.6 $532,805 - $620,898
-2,401 Reduced 26.98%
6,499 $1.62 Million
Q4 2020

Feb 25, 2021

BUY
$216.38 - $257.67 $238,018 - $283,437
1,100 Added 14.1%
8,900 $2.05 Million
Q3 2020

Oct 19, 2020

BUY
$234.65 - $260.95 $1.2 Million - $1.33 Million
5,100 Added 188.89%
7,800 $1.98 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $19,781 - $24,274
100 Added 3.85%
2,700 $637,000
Q1 2020

Apr 28, 2020

SELL
$182.24 - $241.7 $364,480 - $483,400
-2,000 Reduced 43.48%
2,600 $527,000
Q4 2019

Jan 13, 2020

SELL
$189.21 - $243.2 $700,077 - $899,840
-3,700 Reduced 44.58%
4,600 $1.11 Million
Q3 2019

Oct 18, 2019

BUY
$174.11 - $208.62 $1.11 Million - $1.34 Million
6,400 Added 336.84%
8,300 $1.61 Million
Q2 2019

Jul 16, 2019

SELL
$166.7 - $195.41 $1.67 Million - $1.95 Million
-10,000 Reduced 84.03%
1,900 $350,000
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $399,855 - $450,784
-2,158 Reduced 15.35%
11,900 $2.47 Million
Q1 2018

May 01, 2018

BUY
$169.43 - $198.0 $2.38 Million - $2.78 Million
14,058 New
14,058 $2.4 Million
Q4 2017

Feb 01, 2018

SELL
$168.79 - $188.59 $253,185 - $282,885
-1,500 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$167.29 - $191.0 $250,935 - $286,500
1,500
1,500 $280,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.